Webinar: <br src=

Webinar:

Solid Form Development - Embracing Automation


Webinar: <br src=

Webinar:

Solid Form Development - Embracing Automation


 
Home / API Services & Chemical Development /

Since the mid-80s, the use of robotics in drug discovery has become common practice. The development of liquid handling devices and sensitive detectors, together with data processing and control software, allow us to quickly conduct thousands of experiments to identify active compounds, antibodies or genes that modulate particular biomolecular pathways. However, the use of similar strategies in drug development is not yet widely established.

Many of the tests performed in laboratories today usually involve repetitive actions such as moving solutions or weighing samples, which add no value to the project. In this context, the introduction of robots in the lab to perform these mundane and repetitive tasks will enable the scientist to spend their time in activities that increase the value of their research.

During this presentation, we will discuss our journey from a mostly manual tasks lab-based workforce to the introduction of automation platforms in our labs, specifically in the area of solid form screening.  Learn now automation:

  • Reduces errors
  • Ensures reproducibility
  • Increases the efficiency of our processes

Dr. Victor Diaz

Speaker
Dr. Victor Diaz graduated from University of Seville with a BSc (Hons) in chemistry in 1995. He then completed a Ph.D. in organic chemistry and on the design, synthesis and evaluation of glycomimetics of natural occurring azasugars used for the inhibition of glycosidases. Since then he has worked both as a medicinal chemist within the hit identification and lead optimisation teams, leading to the nomination of a number of drug candidates in the protease field and as an early stages preclinical development scientist focusing on the modification and optimisation of the physical and physicochemical attributes of active pharmaceutical ingredients. After holding different leadership positions at Sigma-Aldrich and Johnson Matthey, Victor joined Almac in 2015 to head up the Physical Sciences team and to drive forward the growth of the company through the optimisation of screening and preformulation platforms to enable our clients to have a successful and quicker access to the market.’


Dr. Diaz is currently a Fellow of the Royal Society of Chemistry

(Banner image credit: Univ. Liverpool)

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies